Exiqon partners with MedTrust Online to Promote Molecular Oncology Diagnostic Services to Oncologists
News Jun 03, 2009
Exiqon Diagnostics, announced a strategic commercial partnership with MedTrust Online, an internet based solution provider for oncologists that offers clinically useful knowledge on the latest topics in cancer treatment.
Exiqon Diagnostics will become a content partner by providing a comprehensive suite of oncology molecular diagnostics services to MedTrust Online's Oncocentric oncology portal.
MedTrust Online will add Exiqon Diagnostics service offerings, extensive clinical studies, insurance/billing information, order forms, and live forum case studies available to MedTrust's growing oncology health care provider user base consisting of thousands of medical, gynecologic and surgical oncologists as well as pathologists and support staff nationwide.
"We are pleased to add Exiqon Diagnostics to the growing list of molecular diagnostic companies providing content on the MedTrust Online oncology portal," said Matt Sargent, Vice President of Molecular Diagnostics for MedTrust Online.
"Molecular diagnostic testing options and drug reimbursement data are the two most heavily requested topics from our oncology user base. Our Oncocentric portal allows oncologists to rapidly find the information that they need on new molecular diagnostics to better practice personalized medicine."